Baseline Characteristics in the VERIFY Study: A Randomized Trial Assessing the Durability of Glycaemic Control With Early Vildagliptin-Metformin Combination in Newly Diagnosed Type 2 Diabetes

Diabetic Medicine - United Kingdom
doi 10.1111/dme.13886
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Prospective Randomized Study: Role of Enalapril on Oxidative Stress in Newly Diagnosed Type 2 Diabetes Mellitus and Its Correlation With Glycaemic Status

International Journal of Basic & Clinical Pharmacology
2017English

A Prospective Open Labelled Study of Effect of Vildagliptin With Metformin in Patients With Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology
2019English

Early Glycaemic Control in Metformin Users Receiving Their First Add-On Therapy: A Population-Based Study of 4,734 People With Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

A Randomized, Open Label, Comparative Study of Biotin as an Add-On Therapy to Metformin vs Metformin Alone in Newly Diagnosed Type 2 Diabetes Mellitus Patients

IOSR Journal of Dental and Medical Sciences
2016English

A Retrospective Comparison Study Between the Effectiveness and Safety of Fixed Dose Combination of Vildagliptin Versus Sitagliptin With Metformin in Type 2 Diabetes Mellitus Patients

Indian Journal of Pharmacy Practice
2018English

Use of Metformin and Vildagliptin for Treatment of Type 2 Diabetes in the Elderly

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

A Variant of the Glucose Transporter Gene SLC2A2 Modifies the Glycaemic Response to Metformin Therapy in Recently Diagnosed Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Vildagliptin: Optimal Control in Type 2 Diabetes Mellitus Treatment

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy